Millennium Management
FOMX

Millennium Management’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Millennium Management’s Portfolio FOMX Stock Details FOMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-345,100
Closed -$1.05M – 4848
2019
Q3 		$1.05M Sell
345,100
-486,925
-59% -$1.37M ﹤0.01% 2824
2019
Q2 		$1.98M Buy
832,025
+136,536
+20% +$408K ﹤0.01% 2414
2019
Q1 		$2.61M Sell
695,489
-357,252
-34% -$1.34M ﹤0.01% 2227
2018
Q4 		$3.78M Sell
1,052,741
-100,387
-9% -$437K 0.01% 1776
2018
Q3 		$6.61M Buy
1,153,128
+818,711
+245% +$4.68M 0.01% 1606
2018
Q2 		$1.68M Sell
334,417
-428,879
-56% -$2.21M ﹤0.01% 2514
2018
Q1 		$3.92M Buy
763,296
+19,628
+3% +$118K 0.01% 1952
2017
Q4 		$4.47M Buy
743,668
+33,893
+5% +$204K 0.01% 1794
2017
Q3 		$3.94M Buy
709,775
+586,690
+477% +$3.03M 0.01% 1798
2017
Q2 		$571K Sell
123,085
-130,299
-51% -$582K ﹤0.01% 2748
2017
Q1 		$1.25M Sell
253,384
-26,007
-9% -$250K ﹤0.01% 2264
2016
Q4 		$3.1M Buy
279,391
+204,054
+271% +$1.92M 0.01% 1637
2016
Q3 		$698K Sell
75,337
-122,171
-62% -$1.02M ﹤0.01% 2450
2016
Q2 		$1.25M Buy
197,508
+82,934
+72% +$550K ﹤0.01% 2030
2016
Q1 		$747K Buy
114,574
+2,147
+2% +$13.8K ﹤0.01% 2329
2015
Q4 		$912K Sell
112,427
-45,970
-29% -$344K ﹤0.01% 2350
2015
Q3 		$1.16M Buy
158,397
+131,518
+489% +$1.34M ﹤0.01% 2209
2015
Q2 		$276K Sell
26,879
-30,021
-53% -$332K ﹤0.01% 2916
2015
Q1 		$526K Buy
+56,900
New +$509K ﹤0.01% 2722
2014
Q4 		– Sell
-34,533
Closed -$188K – 4422
2014
Q3 		$188K Buy
+34,533
New +$198K ﹤0.01% 3453

Other funds holding FOMX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Millennium Management's FOMX Position: Q4 2019 in Review

Millennium Management sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q4 2019, closing a stake of 345,100 shares — an estimated $1.05M sold.

Millennium Management first reported a position in FOMX in Q3 2014 and held it in 20 quarters. The position peaked at $6.61M in Q3 2018. 65 funds tracked by Wall St. Rank hold FOMX as of Q4 2019.

  • Millennium Management reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q4 2019 after selling out during the quarter.
  • Millennium Management sold 345,100 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q4 2019, an estimated $1.05M.
  • Millennium Management first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q3 2014 and held it in 20 quarters.
  • Millennium Management's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $6.61M in Q3 2018.
  • 65 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q4 2019.

Based on Millennium Management's 13F filing for Q4 2019, filed 14 Feb 2020.